ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Money Earmarked for WVU Center Could Be Returned To Treasury; BYRD Get Assurances From DeVita

May 31, 1985

Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting

June 25, 2010

Breast Cancer Coalition to Congress: ‘Find a Way To Fund The War,’ Bypass Level Is Not Enough

August 7, 1992

NCI, IARC Sponsors Workshop On EBV

February 14, 1975

Letter to the Editor: NCI Should Continue Supporting Research In Special Populations

July 31, 1998

Senate “Pleased” About Reductions In Incidence And Mortality

October 8, 1999